Definium director granted RSUs and stock options
Definium Therapeutics director Andreas Krebs received new equity awards.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Definium Therapeutics director Andreas Krebs received new equity awards. He was granted 4,666 restricted stock units, each representing one common share, and a stock option covering 19,188 common shares at an exercise price of $24.11 per share. Following the award, he directly holds 19,773 common shares, and the option vests in 12 equal monthly installments, with both the RSUs and option subject to possible acceleration immediately before the next annual meeting if it occurs within one year of grant and he continues in service.
Insider Trade Summary
Grant/Award: 23,854 shares
Grant/Award
2 txns
Insider
Krebs Andreas
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 19,188 | $0.00 | $0.00 |
| Grant/Award | Common Shares | 4,666 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 19,188 contracts (Direct);
Common Shares — 19,773 shares (Direct)
Footnotes (2)
- F1. These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one common share of the Issuer. The RSUs vest as to 1/12th of the underlying shares on each monthly anniversary of the date of the grant, provided, that if the Issuer's annual meeting immediately following the date of grant takes place prior to the first anniversary of the date of grant, any unvested RSUs will vest immediately prior to the Issuer's annual meeting following the date of grant, subject the Reporting Person's continued service through the applicable vesting date.
- F2. The Stock Option vests and becomes exercisable as to 1/12th of the underlying shares on each monthly anniversary of the date of the grant, provided, that if the Issuer's annual meeting immediately following the date of grant takes place prior to the first anniversary of the date of grant, the Stock Option will vest and become exercisable immediately prior to the Issuer's annual meeting following the date of grant, subject to the Reporting Person's continued service through the applicable vesting date.
Key Figures
RSU grant: 4,666 units
Stock option grant size: 19,188 shares
Option exercise price: $24.11/share
+3 more
6 metrics
RSU grant
4,666 units
Each RSU equals one common share
Stock option grant size
19,188 shares
Underlying common shares for new option
Option exercise price
$24.11/share
Exercise price for 19,188-share option
Shares held after grant
19,773 shares
Common shares directly held post-transaction
RSU/option vesting schedule
1/12 monthly
Both RSUs and option vest in 12 monthly installments
Option expiration
June 10, 2036
Expiration date of stock option
Key Terms
restricted stock units, Stock Option (Right to Buy), vest, annual meeting, +1 more
5 terms
restricted stock units financial
"These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one common share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Option (Right to Buy) financial
"The Stock Option vests and becomes exercisable as to 1/12th of the underlying shares"
vest financial
"The RSUs vest as to 1/12th of the underlying shares on each monthly anniversary"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
annual meeting financial
"if the Issuer's annual meeting immediately following the date of grant takes place prior to the first anniversary"
A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.
exercise price financial
"conversion_or_exercise_price": "24.1100""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Definium Therapeutics (DFTX) report for Andreas Krebs?
Definium Therapeutics reported that director Andreas Krebs received equity compensation, including 4,666 restricted stock units and a stock option for 19,188 common shares. These awards were granted at no cash cost to him and are tied to continued board service.
What are the terms of the new stock option granted to Andreas Krebs at Definium Therapeutics (DFTX)?
The stock option covers 19,188 common shares at an exercise price of $24.11 per share. It vests as to one-twelfth of the underlying shares on each monthly anniversary of the grant date, with potential accelerated vesting immediately before the next annual meeting under stated conditions.
How do the restricted stock units for Andreas Krebs at Definium Therapeutics (DFTX) vest?
The 4,666 restricted stock units vest in twelve equal monthly installments starting from the grant date. If the company’s next annual meeting occurs within one year, any remaining unvested units vest immediately before that meeting, assuming he remains in service through the applicable vesting date.
Are the recent Definium Therapeutics (DFTX) insider transactions open-market purchases or sales?
The transactions are equity awards, not open-market trades. Andreas Krebs received restricted stock units and a stock option as compensation, both recorded with code A for grant or award acquisition, so no shares were bought or sold on the open market in this filing.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates